Activest Wealth Management’s Aldeyra Therapeutics ALDX Stock Holding History

Activest Wealth Management’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18.4K	Hold	15,000	–	–	﹤0.01%	463
2026 Q2	$32K	Buy	15,000 +11,000	+275%	+$18.9K	0.01%	347
2026 Q1	$6.76K	Hold	4,000	–	–	﹤0.01%	766
2025 Q4	$20.7K	Buy	4,000 +2,000	+100%	+$10.3K	﹤0.01%	503
2025 Q3	$10.4K	Hold	2,000	–	–	﹤0.01%	497
2025 Q2	$7.66K	Hold	2,000	–	–	﹤0.01%	481
2025 Q1	$11.5K	Hold	2,000	–	–	﹤0.01%	376
2024 Q4	$10K	Hold	2,000	–	–	﹤0.01%	316
2024 Q3	$10.8K	Hold	2,000	–	–	﹤0.01%	314
2024 Q2	$6.62K	Buy	+2,000	New	+$7.83K	﹤0.01%	325

Other funds holding ALDX

Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.68B AUM 22.33% 1-Year Est. Return

Providence Wealth Advisors Frankfort, Illinois $174M AUM 29.13% 1-Year Est. Return

Hikari Power Tokyo, Japan $439M AUM 11.38% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Activest Wealth Management's ALDX Position: Q3 2026 in Review

Activest Wealth Management held its Aldeyra Therapeutics (ALDX) position steady in Q3 2026 at 15,000 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Activest Wealth Management first reported a position in ALDX in Q2 2024 and has held it in 10 quarters since. The position peaked at $32K in Q2 2026. 16 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.

Activest Wealth Management held 15,000 shares of Aldeyra Therapeutics worth $18.4K as of Q3 2026.
Activest Wealth Management left its Aldeyra Therapeutics share count unchanged in Q3 2026.
Aldeyra Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #463 holding.
Activest Wealth Management first reported a position in Aldeyra Therapeutics in Q2 2024 and has held it in 10 quarters since.
Activest Wealth Management's Aldeyra Therapeutics position peaked at $32K in Q2 2026.
16 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.